BCWorldPharm Co Ltd banner
B

BCWorldPharm Co Ltd
KOSDAQ:200780

Watchlist Manager
BCWorldPharm Co Ltd
KOSDAQ:200780
Watchlist
Price: 4 520 KRW 0.89% Market Closed
Market Cap: ₩48.2B

BCWorldPharm Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

BCWorldPharm Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
B
BCWorldPharm Co Ltd
KOSDAQ:200780
Research & Development
-₩9B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
-5%
Yuhan Corp
KRX:000100
Research & Development
-₩198.2B
CAGR 3-Years
-23%
CAGR 5-Years
-7%
CAGR 10-Years
-18%
SK Biopharmaceuticals Co Ltd
KRX:326030
Research & Development
-₩169.7B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Research & Development
-₩195.8B
CAGR 3-Years
-8%
CAGR 5-Years
2%
CAGR 10-Years
-2%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Research & Development
-₩8.7B
CAGR 3-Years
-8%
CAGR 5-Years
17%
CAGR 10-Years
-9%
C
Caregen Co Ltd
KOSDAQ:214370
Research & Development
-₩5.7B
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
No Stocks Found

BCWorldPharm Co Ltd
Glance View

Market Cap
48.2B KRW
Industry
Pharmaceuticals

BCWORLD PHARM.Co., Ltd. engages in the manufacture and development of pharmaceutical products. The company is headquartered in Yeoju, Gyeonggi-Do. The company went IPO on 2014-12-15. The firm's products include anesthetic pain medication such as cancer pain treatment, muscle relaxants, anesthesia and pain relief drugs; circulation contracts such as hypertension and hyperlipidemia; antibiotics such as tuberculosis treatment; other prescription drugs such as peptic ulcer and osteoporosis. In addition, the Company develops improved drugs and new products.

BCWorldPharm Co Ltd Intrinsic Value
LOCKED
Unlock

See Also

What is BCWorldPharm Co Ltd's Research & Development?
Research & Development
-9B KRW

Based on the financial report for Dec 31, 2025, BCWorldPharm Co Ltd's Research & Development amounts to -9B KRW.

What is BCWorldPharm Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-5%

Over the last year, the Research & Development growth was -16%. The average annual Research & Development growth rates for BCWorldPharm Co Ltd have been -2% over the past three years , 1% over the past five years , and -5% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett